SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-006718
Filing Date
2023-10-26
Accepted
2023-10-25 18:18:25
Documents
19
Period of Report
2023-10-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea187278-8k_actavialife.htm   iXBRL 8-K 29313
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF RASNA THERAPEUTICS, INC ea187278ex3-1_actavialife.htm EX-3.1 2956
7 GRAPHIC ex3-1_001.jpg GRAPHIC 398331
8 GRAPHIC ex3-1_002.jpg GRAPHIC 474154
9 GRAPHIC ex3-1_003.jpg GRAPHIC 1294611
10 GRAPHIC ex3-1_004.jpg GRAPHIC 1016329
11 GRAPHIC ex3-1_005.jpg GRAPHIC 287619
  Complete submission text file 0001013762-23-006718.txt   5007647

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rasp-20231024.xsd EX-101.SCH 3070
4 XBRL DEFINITION FILE rasp-20231024_def.xml EX-101.DEF 26169
5 XBRL LABEL FILE rasp-20231024_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE rasp-20231024_pre.xml EX-101.PRE 22357
13 EXTRACTED XBRL INSTANCE DOCUMENT ea187278-8k_actavialife_htm.xml XML 3235
Mailing Address 5 PENN PLAZA, 19TH FLOOR, #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR, #1954 NEW YORK NY 10001 646-396-4087
ACTAVIA LIFE SCIENCES, INC. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191083 | Film No.: 231347094
SIC: 2834 Pharmaceutical Preparations